Category Archives: Regulation

The Daraprim Case: How a Drug’s Price Rose by 75,000 %

By Simon Gottwalt. The recent price hike of Daraprim, a 62 year old medicine used against toxoplasmosis, created a massive public outcry against Turing Pharmaceuticals, who had just acquired the drug, and its CEO Martin Shkreli, making him “the most hated man in … Continue reading

Posted in Pricing, Regulation | Leave a comment

Gilead is Criticized for Restrictions on Generic Hepatitis C Drug Deal

Source: The Wall Street Journal 20 March 2015  In yet another fracas over Gilead Sciences and its hepatitis C treatments, Doctors Without Borders is harshly criticizing the drug maker over an agreement in which several generic companies will sell lower-cost … Continue reading

Posted in Hepatitis C, Regulation, Sofosbuvir | Leave a comment

Indian generic drugs debate heats up

Source: The Lancet India has strongly objected to the findings of new research that raises questions about the quality of drugs manufactured in the country and exported abroad. Sanjeet Bagcchi reports. Findings from a new investigation have raised questions over … Continue reading

Posted in Generics, Quality, Regulation | Tagged , , , | Leave a comment